The eye is regarded as an important organ in the human body. Pollution and stress are two external factors that have an impact on eye health. Fungal keratitis, also known as keratomycosis, is a coronial fungal infection that affects the person’s eye. It is an ocular infection that causes permanent vision loss. FMI presents an …
Monthly Archives: February 2023
Europe is expected to have the second largest share in the Phoropters Market through 2028
Phoropters are medical devices that are used to perform ophthalmic testing. They are commonly referred to as refractors. Ophthalmologists most commonly use photopters during eye examinations. They contain various lenses used for refraction of the eye during sight testing. Phoropters are also used to determine an individual’s refractive error and prescription. To correct vision, phoropters …
Asia Pacific Market for Central Patient Monitoring Systems is expected to grow rapidly | Says FMI Analyst
The healthcare industry is working hard to alleviate the pain points of healthcare professionals. For example, Central Patient Monitoring Systems address the pain point of monitoring a large number of patients. Central patient monitoring systems are computer networks that connect a set number of patient monitors. With the latest insights and statistics from the biggest …
Continuous Glucose Monitoring Systems Market Demand for continuous glucose monitoring systems in Europe is expected to register a growth of 10.2% CAGR from 2022 to 2032
[Report of 261 Pages] The market for continuous glucose monitoring systems is anticipated to reach a valuation of US$ 1.1 billion in 2022 and then grow at a CAGR of 10.8% to US$ 3.0 billion by the end of 2032. In 2021, the global continuous glucose monitoring systems market will be dominated by sensors, with a share …
With Diabetic Population exploding, the global Insulin Biosimilars Market to reach US$ 5.88 Bn by the year 2032 at a robust CAGR of 21.5% in the forecast period 2022 to 32
The global insulin biosimilars market is worth US$ 1.47 Bn as of now and expected to reach US$ 5.88 Bn by the year 2032 at a stellar CAGR of 21.5% between 2022 and 2032. Biosimilar insulin has the capacity of reducing treatment costs of diabetes, increasing insulin treatment’s accessibility, and expanding number of various insulin …
Asia Pacific Automotive Telematics Market Growth Poised to Register 15.6% CAGR through 2032
Asia Pacific Automotive Telematics Market Growth was worth US$ 80.18 Billion in the year 2022 and is expected to reach US$ 341.7 Billion by the year 2032 at a sizzling CAGR of 15.6% between 2022 and 2032. Key Takeaways from APAC Automotive Telematics Market China is subject to stern government policies for installing telematics and …
Surgical Sutures Market to Garner US$ 13.9 Bn by the year 2032 Attributed to Their Extensive Application in the Healthcare Industry
The global surgical sutures market is expanded at a healthy CAGR of 5.4% across the projection period from 2022 to 2032. The market is expected to enjoy a valuation of around US$ 8.2 Bn by the end of the year 2022 and further reach an estimation of around US$ 13.9 Bn by the year 2032. …
Pap Tests to Contribute the Most to HPV Testing and Pap Test Market throughout the Analysis Period, States Future Market Insights
The Global HPV testing and Pap Test Market was valued at US$ 2.2 Bn in 2021 and is expected to reach US$ 15 Bn by 2032, finds Future Market Insights (FMI) in a recent market survey. As per the findings of the report, Pap Testing will remain pivotal for the market as the bulk of …
Increasing Demand for Healthcare Sector and Need for Robust Security Led to a Surge in Medical Terahertz Technology Sales | FMI Taps a Market Valuation of US$ 135.29 Mn in 2022
According to a report published by FMI, the global medical terahertz technology market will be valued at US$ 135.29 Mn in 2022. It is expected to grow at a CAGR of 17.1% during the forecast period, reaching a value of US$ 768.05 Mn by 2032. A fast-growing field of terahertz technology is driving market growth …
Ferric Carboxymaltose to Generate nearly 50% of the Intravenous Iron Drugs Market throughout the Analysis Period, according to Future Market Insights
Global Intravenous Iron Drugs Market was valued at US$ 2.6 Bn in 2021 and is expected to reach US$ 6.3 Bn by 2032, finds FMI in a recent market survey. As per the findings of the report, Intravenous Iron Drugs revenue through Ferric Carboxymaltose will garner significant demand in the market as the bulk of …